X-linked myotubular myopathy

From WikiMD's Medical Encyclopedia

Revision as of 19:36, 8 April 2025 by Prab (talk | contribs) (CSV import)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC

X-linked myotubular myopathy
Synonyms Myotubular myopathy, MTM1
Pronounce
Specialty Neurology, Genetics
Symptoms Muscle weakness, hypotonia, respiratory difficulties
Complications N/A
Onset Infancy
Duration Lifelong
Types N/A
Causes Mutations in the MTM1 gene
Risks Male gender (due to X-linked inheritance)
Diagnosis Genetic testing, Muscle biopsy
Differential diagnosis Congenital myopathy, Spinal muscular atrophy
Prevention N/A
Treatment Supportive care, Physical therapy, Respiratory support
Medication N/A
Prognosis Variable, often severe
Frequency Rare
Deaths


X-linked myotubular myopathy (XLMTM) is a type of centronuclear myopathy, which is a group of rare, inherited conditions that affect the muscles. XLMTM, specifically, occurs almost exclusively in males and is characterized by progressive muscle weakness (myopathy) and decreased muscle tone (hypotonia) that can range from mild to severe. The muscle problems impair the development of motor skills such as sitting, standing, and walking, and may disrupt primary functions such as breathing and feeding. XLMTM is caused by changes (mutations) in the MTM1 gene and is inherited in an X-linked recessive manner. Treatment is based on the signs and symptoms present in each person and may include physical and/or occupational therapy and assistive devices to help with mobility, eating and/or breathing.

Other Names[edit]

X-linked centronuclear myopathy; XLCNM; XLMTM

Cause[edit]

This condition is caused by mutations in the myotubularin (MTM1) gene which is located on the long arm of the X chromosome (Xq28).

Signs and symptoms[edit]

30%-79% of people have these symptoms

Less common symptoms[edit]

Inheritance[edit]

X-linked recessive inheritance

Diagnosis[edit]

  • Making a diagnosis for a genetic or rare disease can often be challenging.
  • Healthcare professionals typically look at a person‚Äôs medical history, symptoms, physical exam, and laboratory test results in order to make a diagnosis.

Genetic testing[edit]

  • The Genetic Testing Registry (GTR) provides information about the genetic tests for this condition.
  • The intended audience for the GTR is health care providers and researchers. Patients and consumers with specific questions about a genetic test should contact a healthcare provider or a genetics professional

Presentation[edit]

  • This condition is found almost always in male infants.
  • It is one of the severest congenital muscle diseases and is characterized by marked muscle weakness, hypotonia and feeding and breathing difficulties.

Genetics[edit]

  • Many clinicians and researchers use the abbreviations XL-MTM, XLMTM or X-MTM to emphasize that the genetic abnormality for myotubular myopathy (MTM) is X-linked (XL), having been identified as occurring on the X chromosome.
  • The specific gene on the X chromosome is referred to as MTM-1.
  • In theory, some cases of CNM may be caused by an abnormality on the X chromosome, but located at a different site from the gene MTM1, but currently MTM1 is the only X-linked genetic mutation site identified for myotubular or centronuclear myopathy.
  • Clinical suspicion for X-linked inheritance would be a disease affecting multiple boys (but no girls) and a pedigree chart showing inheritance only through the maternal (mother‚Äôs) side of each generation.




This article is a medical stub. You can help WikiMD by expanding it!
PubMed
Wikipedia
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.